Eisai (OTCMKTS:ESALY) Stock Crosses Below 50-Day Moving Average – Time to Sell?

Eisai Co., Ltd. (OTCMKTS:ESALY)’s share price crossed below its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of $61.51 and traded as low as $61.00. Eisai shares last traded at $61.51, with a volume of 331,800 shares changing hands.

Eisai Stock Down 2.1%

The company has a current ratio of 2.20, a quick ratio of 1.77 and a debt-to-equity ratio of 0.10. The company’s 50-day moving average is $61.51 and its 200 day moving average is $61.51. The stock has a market capitalization of $17.64 billion, a PE ratio of 70.70, a price-to-earnings-growth ratio of 2.46 and a beta of 0.31.

Eisai Company Profile

Eisai Co, Ltd. is a research-driven global pharmaceutical company headquartered in Tokyo, Japan. Founded in 1941 by Toyoji Naito, Eisai focuses on the discovery, development, manufacture and commercialization of prescription medicines and related healthcare products. The company emphasizes neuroscience and oncology as core therapeutic areas and invests in both small-molecule and biologic research to address unmet medical needs.

Among its well-known products, Eisai developed and markets Aricept (donepezil), a widely used treatment for the symptoms of Alzheimer’s disease, and LENVIMA (lenvatinib), an oncology therapy for several tumor types.